Vermont Business Times
SEE OTHER BRANDS

Fresh news on business and economy in Vermont

Vermont Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Business Times.

Press releases published on August 4, 2025

Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025

Kymera Therapeutics to Report Second Quarter 2025 Financial Results on August 11, 2025

WATERTOWN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report second quarter …

Descartes Acquires Finale Inventory

Descartes Acquires Finale Inventory

Broadens Multi-Channel Inventory Management Capabilities to Scale Across Ecommerce Operations of all Sizes WATERLOO, Ontario and ATLANTA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX:DSG) (Nasdaq:DSGX), the global leader in uniting …

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update

—Q2 2025 ORLADEYO net revenue of $156.8 million (+45 percent y-o-y)— —Q2 2025 operating profit of $29.8 million (+239 percent y-o-y); non-GAAP operating profit of $57.0 million (+160 percent y-o-y)— —Company makes additional $50 million paydown of term …

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

WARREN, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …

GXO Strengthens Aerospace Business with RTX’s Pratt & Whitney Contract Renewal in the U.S.

GXO Strengthens Aerospace Business with RTX’s Pratt & Whitney Contract Renewal in the U.S.

GXO has managed Pratt …

Accumulus Synergy Spins Out Accumulus Technologies to Scale Proven Regulatory Platform and Accelerate Global Access to Therapies

Accumulus Synergy Spins Out Accumulus Technologies to Scale Proven Regulatory Platform and Accelerate Global Access to Therapies

BURLINGAME, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- In a bold move to accelerate regulatory innovation and meet growing global demand, Accumulus Synergy, a nonprofit industry association, today announced the formation of Accumulus Technologies, a new …

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

Second quarter 2025 total revenue of $141.1 million, including BRIUMVI U.S. net revenue of $138.8 million Raises full year 2025 BRIUMVI U.S. net revenue target to approximately $570 - $575 million Conference call to be held today, Monday, August 4, 2025, …

onsemi Powers Xiaomi’s YU7 Electric SUV Line-Up

onsemi Powers Xiaomi’s YU7 Electric SUV Line-Up

Scottsdale, Ariz., Aug. 04, 2025 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) today announced that select Xiaomi YU7 electric SUV models feature an advanced 800V drive platform powered by onsemi’s EliteSiC M3e technology. The EliteSiC M3e platform features …

Blade announces sale of Passenger Division to Joby, Transitions to Pure-Play Medical Services and Logistics Business

Blade announces sale of Passenger Division to Joby, Transitions to Pure-Play Medical Services and Logistics Business

Blade Passenger division to be sold to Joby Aviation for up to $125 million Blade’s Medical division will remain public and rebrand as Strata post-close, focusing entirely on its rapidly growing contractual medical services and logistics business Long-term …

Village Farms International Announces Expansion of Cultivation Capacity in Delta, British Columbia

Village Farms International Announces Expansion of Cultivation Capacity in Delta, British Columbia

Company to convert incremental 550,000 sq. ft. of advanced greenhouse to cannabis production Phased expansion plan expected to provide additional 40 tonnes of annual production once complete Increased capacity will support continued profitable growth in …

Kaspi.kz 2Q & 1H 2025 Financial Results

Kaspi.kz 2Q & 1H 2025 Financial Results

ALMATY, Kazakhstan, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”) (Nasdaq:KSPI) which operates the Kaspi.kz and Kaspi Pay Super Apps in Kazakhstan and owns 66.35% of Hepsiburada in Türkiye, today published its unaudited …

3D Systems Announces Date of Second Quarter 2025 Financial Results

3D Systems Announces Date of Second Quarter 2025 Financial Results

ROCK HILL, S.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today it will release its financial results for the second quarter 2025 after the U.S. stock markets close on Monday, August 11, 2025. The company will hold a conference …

Nevada Gold Mines and Komatsu Launch First-of-Its-Kind Autonomous Haulage Partnership in the U.S.

Nevada Gold Mines and Komatsu Launch First-of-Its-Kind Autonomous Haulage Partnership in the U.S.

ELKO, Nev., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nevada Gold Mines (NGM) and Komatsu have officially launched a pioneering partnership to elevate workplace safety and enhance operational efficiency through the deployment of Komatsu’s FrontRunner Autonomous …

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) announced today they have entered into a definitive merger …

DallasNews Corporation Files Preliminary Proxy Statement

DallasNews Corporation Files Preliminary Proxy Statement

-- Reiterates Proposed Merger with Hearst as Path to Certain, Premium Shareholder Value -- DALLAS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company” or “DallasNews”), the holding company of The Dallas Morning News and …

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) announced today they have entered into a definitive merger agreement ( …

Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Total 2Q 2025 net product revenue of $150.0 million, representing growth of 72% year-over-year and 24% sequentially AUVELITY® 2Q 2025 net product sales of $119.6 million, representing growth of 84% year-over-year and 24% sequentially SUNOSI® 2Q 2025 net …

TMC and Tonga Announce Updated Sponsorship Agreement for Tonga Offshore Mining Ltd (TOML)

TMC and Tonga Announce Updated Sponsorship Agreement for Tonga Offshore Mining Ltd (TOML)

The Kingdom of Tonga and TMC’s subsidiary, Tonga Offshore Mining Ltd (TOML), signed a revised Sponsorship Agreement, updating the terms of their agreement signed in 2021 The Government of the Kingdom of Tonga welcomes the new agreement which will ensure …

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2025 sowie Informationen zur Geschäftsentwicklung

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2025 sowie Informationen zur Geschäftsentwicklung

BioNTech treibt Onkologiestrategie voran, u.a. mit zwei bekanntgegeben Transaktionen, und setzt damit den Fokus auf die zwei tumorübergreifenden (Pan-Tumor-)Programme: mRNA-Krebsimmuntherapie-Kandidaten und BNT327, ein gegen PD-L11 und VEGF-A gerichteter …

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific antibody candidate targeting PD-L11 and VEGF-A Entered a …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions